Sirtris Pharmaceuticals
id:
sirtris-pharmaceuticals-252-2234644
title:
Sirtris Pharmaceuticals
text:
Sirtris Pharmaceuticals, Inc. was a biotechnology company based in Cambridge, MA that developed therapies for type 2 diabetes, cancer, and other diseases. Conceived in 2004 by Harvard University biologist David Sinclair and Andrew Perlman, and founded that year by Sinclair and Perlman, along with Christoph Westphal, Richard Aldrich, Richard Pops, and Paul Schimmel, the company was focused on developing Sinclair's research into activators of sirtuins, work that began in the laboratory of Leonard
brand slug:
wiki
category slug:
encyclopedia
description:
Biotechnology company in Massachusetts
original url:
https://en.wikipedia.org/wiki/Sirtris_Pharmaceuticals
date created:
date modified:
2024-01-04T12:19:23Z
main entity:
{"identifier":"Q7530650","url":"https://www.wikidata.org/entity/Q7530650"}
image:
fields total:
13
integrity:
14